Ayala Pharmaceuticals Inc (ADXS)
0.555
0.00 (0.00%)
USD |
OTCM |
Apr 26, 14:50
Ayala Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
Date | Value |
---|---|
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
--
Maximum
Dec 2019
--
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
Taro Pharmaceutical Industries Ltd | 0.00 |
InspireMD Inc | 0.00 |
BiomX Inc | -- |
Alpha Tau Medical Ltd | -- |
Pluri Inc | 5.547 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 16.58M |
Total Liabilities (Quarterly) | 41.00M |
Shareholders Equity (Quarterly) | -24.42M |